[{"address1": "Tashirodaikan-machi 408", "city": "Tosu", "zip": "841-0017", "country": "Japan", "phone": "81 3 5293 1720", "fax": "81 3 5293 1724", "website": "https://www.global.hisamitsu", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.", "fullTimeEmployees": 2759, "companyOfficers": [{"maxAge": 1, "name": "Mr. Kazuhide  Nakatomi", "age": 51, "title": "President, CEO & Director", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naruhito  Higo", "title": "Executive VP, Head of Global Technology & Head of Quality Assurance Division", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nobuo  Tsutsumi", "age": 59, "title": "Exe Officer of Legal Affairs, Prod Environment, Reliability Assurance & Compliance and Director", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kosuke  Sugiyama", "age": 71, "title": "Executive MD of Human Resources, Research & Development, Corporate Planning and Director", "yearBorn": 1952, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Tetsuo  Akiyama", "title": "Senior Managing Executive Officer, Head of Business Operations & Head of BU", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kyu  Saito", "age": 60, "title": "MD, Executive Officer, GM of Global Business & Director", "yearBorn": 1963, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shinichi  Murayama", "age": 56, "title": "Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mitsutoshi  Tsuruta", "title": "Senior Executive Officer & GM of Pharmaceutical Business Division", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Masaya  Okuno", "title": "Senior Executive Officer and GM of the Pharmaceuticals & Cosmetics Division", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Koji  Takiyama", "age": 52, "title": "Executive Officer, GM of President's Office & Director", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 1, "boardRisk": 9, "compensationRisk": 1, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1725148800, "maxAge": 86400, "priceHint": 2, "open": 23.7001, "dayLow": 23.7001, "dayHigh": 24.559, "regularMarketOpen": 23.7001, "regularMarketDayLow": 23.7001, "regularMarketDayHigh": 24.559, "dividendRate": 0.57, "dividendYield": 0.0231, "exDividendDate": 1740614400, "payoutRatio": 0.44, "beta": 0.422, "trailingPE": 19.805645, "volume": 1351, "regularMarketVolume": 1351, "bid": 25.34, "ask": 30.34, "marketCap": 1911756032, "fiftyTwoWeekLow": 23.7001, "fiftyTwoWeekHigh": 36.0, "priceToSalesTrailing12Months": 0.013146446, "fiftyDayAverage": 24.559, "twoHundredDayAverage": 27.924496, "trailingAnnualDividendRate": 85.0, "trailingAnnualDividendYield": "Infinity", "currency": "USD", "enterpriseValue": -117466767360, "profitMargins": 0.10114, "floatShares": 52762303, "sharesOutstanding": 73343104, "heldPercentInsiders": 0.22298999, "heldPercentInstitutions": 0.30974, "bookValue": 3607.414, "priceToBook": 0.006807924, "lastFiscalYearEnd": 1709164800, "nextFiscalYearEnd": 1740700800, "mostRecentQuarter": 1717113600, "earningsQuarterlyGrowth": 0.183, "netIncomeToCommon": 14707999744, "trailingEps": 1.24, "enterpriseToRevenue": -0.808, "enterpriseToEbitda": -6.46, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "HTSUF", "underlyingSymbol": "HTSUF", "shortName": "HISAMITSU PHARMACEUTICAL CO INC", "longName": "Hisamitsu Pharmaceutical Co., Inc.", "firstTradeDateEpochUtc": 1285248600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "68e53468-a72d-337b-ad3c-873ee7761bcb", "gmtOffSetMilliseconds": -14400000, "currentPrice": 24.559, "recommendationKey": "none", "totalCash": 122680999936, "totalCashPerShare": 1672.7, "ebitda": 18183000064, "totalDebt": 1130000000, "quickRatio": 2.961, "currentRatio": 3.5, "totalRevenue": 145419993088, "debtToEquity": 0.423, "revenuePerShare": 1907.955, "returnOnAssets": 0.02457, "returnOnEquity": 0.05761, "earningsGrowth": 0.226, "revenueGrowth": 0.116, "grossMargins": 0.55741, "ebitdaMargins": 0.12504, "operatingMargins": 0.11589, "financialCurrency": "JPY", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]